BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Han JH, Kim DG, Na GH, Kim EY, Lee SH, Hong TH, You YK. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma. World J Gastroenterol 2014; 20(45): 17132-17140 [PMID: 25493027 DOI: 10.3748/wjg.v20.i45.17132]
URL: https://www.wjgnet.com/1007-9327/full/v20/i45/17132.htm
Number Citing Articles
1
Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, Floriane Sellier, Paul Castellani, Valerie Oules, Herve Perrier, Gaëlle Lefolgoc, Bernard Pol, Manuela Campanile, Olivier Bayle, Patrick Beaurain, Olivier Monnet, Marc Bourlière. Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals: a case–control studyEuropean Journal of Gastroenterology & Hepatology 2018; 30(4): 368 doi: 10.1097/MEG.0000000000001082
2
Yan Zhou, Lijuan Liu, Youyi Liu, Ping Zhou, Qiujin Yan, Honglian Yu, Xiaobei Chen, Fan Zhu. Implication of human endogenous retrovirus W family envelope in hepatocellular carcinoma promotes MEK/ERK-mediated metastatic invasiveness and doxorubicin resistanceCell Death Discovery 2021; 7(1) doi: 10.1038/s41420-021-00562-5
3
René Fahrner, Felix Dondorf, Michael Ardelt, Yves Dittmar, Utz Settmacher, Falk Rauchfuß. Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survivalWorld Journal of Gastroenterology 2015; 21(42): 12071-12082 doi: 10.3748/wjg.v21.i42.12071
4
Fu He, Kangjian Song, Ge Guan, Junyu Huo, Yang Xin, Tianxiang Li, Chao Liu, Qingwei Zhu, Ning Fan, Yuan Guo, Liqun Wu. The Phenomenon of Gene Rearrangement is Frequently Associated with TP53 Mutations and Poor Disease-Free Survival in Hepatocellular CarcinomaPharmacogenomics and Personalized Medicine 2021; : 723 doi: 10.2147/PGPM.S313848
5
Chihiro Dohi, Kazuhiro Nouso, Koji Miyahara, Yuki Morimoto, Nozomu Wada, Hideaki Kinugasa, Yasuto Takeuchi, Kenji Kuwaki, Hideki Onishi, Fusao Ikeda, Shinichiro Nakamura, Hidenori Shiraha, Akinobu Takaki, Hiroyuki Okada. Potential of alpha‐fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinomaHepatology Research 2016; 46(9): 916 doi: 10.1111/hepr.12636
6
Dongsub Jeon, Won-Mook Choi, Jin-Sun Kim, Yusun Jung, Su-Yeon Lee, Haeng Ran Seo, Kang Mo Kim. Serum Sorbitol Dehydrogenase as a Novel Prognostic Factor for Hepatocellular Carcinoma after Surgical ResectionCancers 2021; 13(23): 6143 doi: 10.3390/cancers13236143
7
Lisa A. Min, Francesca Castagnoli, Wouter V. Vogel, Jisk P. Vellenga, Joost J.M. van Griethuysen, Max J. Lahaye, Monique Maas, Regina G.H. Beets Tan, Doenja M.J. Lambregts. A decade of multi-modality PET and MR imaging in abdominal oncologyThe British Journal of Radiology 2021; 94(1126) doi: 10.1259/bjr.20201351
8
Arno Kornberg, Helmut Friess. 18F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approachesTherapeutic Advances in Gastroenterology 2019; 12 doi: 10.1177/1756284819836205
9
Arno Kornberg, Martina Schernhammer, Helmut Friess. 18F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular CarcinomaJournal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00014
10
Sang Mi Lee, Hong Soo Kim, Sangheun Lee, Jeong Won Lee. Emerging role of <sup>18</sup>F-fluorodeoxyglucose positron emission tomography for guiding management of hepatocellular carcinomaWorld Journal of Gastroenterology 2019; 25(11): 1289-1306 doi: 10.3748/wjg.v25.i11.1289
11
Ikuo Nakamura, Tomoaki Yoh, Takashi Nishimura, Masayuki Okuno, Tomohiro Okamoto, Hideaki Sueoka, Kenjiro Iida, Masaharu Tada, Takamichi Ishii, Satoru Seo, Yasuhiro Fujimoto, Hiroko Iijima, Seiko Hirono, Etsuro Hatano. A classification model for resectability in hepatocellular carcinoma patientsHepatology Research 2024;  doi: 10.1111/hepr.14108
12
Yoshikuni Inokawa, Kenichi Inaoka, Fuminori Sonohara, Masamichi Hayashi, Mitsuro Kanda, Shuji Nomoto. Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factorsOncology Letters 2016; 12(5): 3662 doi: 10.3892/ol.2016.5141
13
Alastair D Burt, Venâncio Alves, Pierre Bedossa, Andrew Clouston, Maria Guido, Stefan Hübscher, Sanjay Kakar, Irene Ng, Young N Park, Helen Reeves, Judith Wyatt, Matthew M Yeh, David W Ellis. Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)Histopathology 2018; 73(3): 369 doi: 10.1111/his.13520
14
René Fahrner, Sandra GC Dennler, Daniel Inderbitzin. Risk of malignancy in Caroli disease and syndrome: A systematic reviewWorld Journal of Gastroenterology 2020; 26(31): 4718-4728 doi: 10.3748/wjg.v26.i31.4718
15
Ningbin Luo, Wenzhu Li, Jisheng Xie, Danhui Fu, Lidong Liu, Xiangyang Huang, Danke Su, Guanqiao Jin. Preoperative normalized iodine concentration derived from spectral CT is correlated with early recurrence of hepatocellular carcinoma after curative resectionEuropean Radiology 2021; 31(4): 1872 doi: 10.1007/s00330-020-07330-6
16
Qinqin Liu, Jing Li, Fei Liu, Weilin Yang, Jingjing Ding, Weixia Chen, Yonggang Wei, Bo Li, Lu Zheng. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomyCancer Imaging 2020; 20(1) doi: 10.1186/s40644-020-00360-9
17
Itsuko Chih-Yi Chen, Leona Bettina P Dungca, Chee-Chien Yong, Chao-Long Chen. Sequential living donor liver transplantation after liver resection optimizes outcomes for patients with high-risk hepatocellular carcinomaHepatobiliary & Pancreatic Diseases International 2024;  doi: 10.1016/j.hbpd.2024.10.003
18
Jun-yi Shen, Chuan Li, Tian-fu Wen, Lv-nan Yan, Bo Li, Wen-tao Wang, Jia-yin Yang, Ming-qing Xu. Alpha fetoprotein changes predict hepatocellular carcinoma survival beyond the Milan criteria after hepatectomyJournal of Surgical Research 2017; 209: 102 doi: 10.1016/j.jss.2016.10.005
19
Tatsuya Orimo, Toshiya Kamiyama, Kenji Wakayama, Shingo Shimada, Akihisa Nagatsu, Yoh Asahi, Yuzuru Sakamoto, Hirofumi Kamachi, Akinobu Taketomi. Hepatectomy Combined with Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement: A Propensity Score-Matched AnalysisAnnals of Surgical Oncology 2020; 27(11): 4153 doi: 10.1245/s10434-020-08754-6
20
Lian-Feng Liu, Zhan-Ling Ding, Jian-Hong Zhong, Hong-Xue Li, Jun-Jie Liu, Hang Li, Le-Qun Li. Contrast-Enhanced Ultrasound to Monitor Early Recurrence of Primary Hepatocellular Carcinoma after Curative TreatmentBioMed Research International 2018; 2018: 1 doi: 10.1155/2018/8910562
21
Hao Song, Na Ding, Shang Li, Jianlong Liao, Aimin Xie, Youtao Yu, Chunlong Zhang, Caifang Ni. Identification of Hub Genes Associated With Hepatocellular Carcinoma Using Robust Rank Aggregation Combined With Weighted Gene Co-expression Network AnalysisFrontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00895
22
Wenzhi Jia, Qianyun Wu, Xiaofeng Yu, Mengqin Shen, Ruixue Zhang, Jiajin Li, Li Zhao, Gang Huang, Jianjun Liu. Prognostic values of ALDOB expression and 18F-FDG PET/CT in hepatocellular carcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1044902
23
Hongfen Wu, Guangcong Zhang, Zhi Li, Jiamei Ma, Xiangyang Han, Tian Xiang, Xuemei Jiang. Thrombospondin-4 expression as a prognostic marker in hepatocellular carcinomaGene 2019; 696: 219 doi: 10.1016/j.gene.2019.02.049
24
Teng Zhao, Longjiu Cui, Aijun Li. The significance of RDW in patients with hepatocellular carcinoma after radical resectionCancer Biomarkers 2016; 16(4): 507 doi: 10.3233/CBM-160591
25
Jin-Chiao Lee, Chih-Hsien Cheng, Yu-Chao Wang, Tsung-Han Wu, Chen-Fang Lee, Ting-Jung Wu, Hong-Shiue Chou, Kun-Ming Chan, Wei-Chen Lee. Clinical relevance of alpha-fetoprotein in determining resection margin for hepatocellular carcinomaMedicine 2019; 98(11): e14827 doi: 10.1097/MD.0000000000014827
26
Jisen Cao, Ruiqiang Zhang, Ye Zhang, Yijun Wang. Risk Factors Affecting the Recurrence-Free Survival of Hepatocellular Carcinoma After Hepatectomy: a Meta-analysisIndian Journal of Surgery 2022; 84(S2): 373 doi: 10.1007/s12262-022-03287-6
27
Chetana Lim, Chady Salloum, Julia Chalaye, Eylon Lahat, Charlotte E. Costentin, Michael Osseis, Emmanuel Itti, Cyrille Feray, Daniel Azoulay. 18F-FDG PET/CT predicts microvascular invasion and early recurrence after liver resection for hepatocellular carcinomaHPB 2019; 21(6): 739 doi: 10.1016/j.hpb.2018.10.007
28
Chunxiao Sui, Qian Su, Kun Chen, Rui Tan, Ziyang Wang, Zifan Liu, Wengui Xu, Xiaofeng Li. 18F-FDG PET/CT-based habitat radiomics combining stacking ensemble learning for predicting prognosis in hepatocellular carcinoma: a multi-center studyBMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-13206-5
29
Toar J.M. Lalisang, Yefta Moenadjat, Nurjati C. Siregar, Marini Stephanie. Overexpression of p53 in extra large (more than 10 cm) hepatocellular carcinomaMedical Journal of Indonesia 2018; 27(2) doi: 10.13181/mji.v27i2.1980
30
Shinji Itoh, Tomoharu Yoshizumi, Yoshiyuki Kitamura, Kyohei Yugawa, Norifumi Iseda, Tomonari Shimagaki, Yoshihiro Nagao, Takeo Toshima, Noboru Harada, Kenichi Kohashi, Shingo Baba, Kousei Ishigami, Yoshinao Oda, Masaki Mori. Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular FormationHepatology Communications 2021; 5(7): 1278 doi: 10.1002/hep4.1715
31
Da-Wei Sun, Lin An, Feng Wei, Lin Mu, Xiao-Ju Shi, Chuan-Lei Wang, Zheng-Wei Zhao, Teng-Fei Li, Guo-Yue Lv. Prognostic significance of parameters from pretreatment 18F-FDG PET in hepatocellular carcinoma: a meta-analysisAbdominal Radiology 2016; 41(1): 33 doi: 10.1007/s00261-015-0603-9